Shared Monitoring and a Clinical Scenario

A panelist describes how the treating center, local oncologist, patient, and caregivers share responsibility for monitoring after CAR T-cell therapy, including warning symptoms, immune monitoring, and infection prevention. The moderator then presents a clinical scenario of a 64-year-old patient at first relapse who lives about 2 hours from the nearest CAR T-cell center and has a caregiver who works full time. Panelists discuss how patient priorities shape the choice of therapy, when the call to the treating center should happen, and what to have ready.